Vilya Company
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.
Headquarters:
Seattle, Washington, United States
Last Funding Type:
Series A
Investors Number:
1.0
Last Funding Date:
2022-08-29
Total Funding:
50000000.0
Founded Date:
2022-01-01
Industry:
Early Drug Development
Funding Status:
Early Stage Venture